Philadelphia-Negative Myeloproliferative Neoplasms: Laboratory Workup in the Era of Next-Generation Sequencing

Current Hematologic Malignancy Reports
Zhuang ZuoC Cameron Yin

Abstract

To review the impact of next-generation sequencing (NGS) on laboratory approach of myeloproliferative neoplasms (MPNs). Next-generation sequencing has provided valuable information on the mutational landscape of MPNs and has been used for various applications, including diagnosis, risk stratification, monitoring of residual disease or disease progression, and target therapy. Most commonly, targeted sequencing of a panel of genes that have been shown to be recurrently mutated in myeloid neoplasms is used. Although numerous studies have shown the benefit of using NGS in the routine clinical care of MPN patients, the complexity of NGS data and how these data may contribute to the clinical outcome have limited the development of a standard clinical guideline. We review recent literature and discuss how to interpret and use NGS data in the clinical care of MPN patients.

References

Mar 23, 2005·Lancet·E Joanna BaxterUNKNOWN Cancer Genome Project
Apr 29, 2005·The New England Journal of Medicine·Robert KralovicsRadek C Skoda
Feb 3, 2007·The New England Journal of Medicine·Linda M ScottAnthony R Green
Jul 13, 2007·Leukemia·A M VannucchiUNKNOWN MPD Research Consortium
May 29, 2009·The New England Journal of Medicine·François DelhommeauOlivier A Bernard
Nov 27, 2009·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Leslie I GoldJoanne E Murphy-Ullrich
Sep 17, 2010·The New England Journal of Medicine·Terra L LashoAyalew Tefferi
May 4, 2011·Leukemia·F StegelmannK Döhner
Sep 13, 2011·Nature·Kenichi YoshidaSeishi Ogawa
Sep 17, 2011·Blood·Paola GuglielmelliAlessandro M Vannucchi
Mar 2, 2012·The New England Journal of Medicine·Srdan VerstovsekHagop M Kantarjian
Apr 27, 2013·Leukemia·A M VannucchiA Tefferi
May 10, 2013·The New England Journal of Medicine·Julia E MaxsonJeffrey W Tyner
Dec 12, 2013·The New England Journal of Medicine·Thorsten KlampflRobert Kralovics
Dec 12, 2013·The New England Journal of Medicine·J NangaliaA R Green
Dec 29, 2013·Blood·Giada RotunnoUNKNOWN Associazione Italiana per la Ricerca sul Cancro Gruppo Italiano Malattie Mieloproliferative Investigators
Jul 6, 2014·Blood·Elisa RumiUNKNOWN Associazione Italiana per la Ricerca sul Cancro Gruppo Italiano Malattie Mieloproliferative Investigators
Dec 18, 2014·Proceedings of the National Academy of Sciences of the United States of America·Raajit RampalRoss L Levine
Feb 12, 2015·The New England Journal of Medicine·Christina A OrtmannAnthony R Green
Apr 9, 2015·American Journal of Hematology·Michelle A ElliottAyalew Tefferi

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Sequencing

Several sequencing approaches are employed to understand and examine tumor development and progression. These include whole genome as well as RNA sequencing. Here is the latest research on cancer sequencing.